Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
38 /100
MEDIUM RISK
Score updated Jul 28, 2026

SPRY — ARS Pharmaceuticals, Inc. Dilution Risk Tracker

Track SPRY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SPRY — Get alerts when the score changes →

As of July 28, 2026, ARS Pharmaceuticals, Inc. (SPRY) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. ARS Pharmaceuticals, Inc. has a market capitalization of $900.68M, 99.30M shares outstanding, 204 institutional holders tracked. Key dilution vectors include approximately 23 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SPRY.
🔔 Track SPRY — Get forecast alerts →

Market Data

Market Cap$900.68M
Shares Outstanding99.30M
Float42.45M
Cash$200.97M
Debt$96.52M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.8% shares (2026Q1 vs prior)
204 institutional holders · 99.21M shares
#1 RA CAPITAL MANAGEMENT, L.P. 10.86M shares
#2 ORBIMED ADVISORS LLC 8.29M shares
#3 Rubric Capital Management LP 8.00M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest22.67M
Days to Cover15.3
% of Float53.4%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2022-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for SPRY Shareholders

ARS Pharmaceuticals, Inc. (SPRY) has a DilutionScore of 38/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

DilutionWatch's EDGAR monitoring for SPRY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for SPRY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for SPRY alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding SPRY's Dilution Risk Factors

Primary Risk Drivers

The two highest-risk factors for SPRY are Offering Ability and Cash Runway. Offering Ability scores at a moderate level, indicating the company has the capacity to raise capital through equity offerings, which can dilute existing shareholders. Cash Runway is also elevated, suggesting that while the company currently has sufficient cash reserves to operate for about 23 months, this buffer is not infinite. A higher Cash Runway score implies a greater likelihood of needing additional funding, which could lead to further issuance of shares and subsequent dilution.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently low-risk indicators. Float Risk at a moderate level suggests that the company's share distribution is not overly concentrated among a small group of holders, reducing the potential for sudden large-scale selling or manipulation. Warrant Exposure also remains manageable, meaning warrants are not expected to significantly increase the outstanding share count in the near term. A change in either area could become concerning if the company announces new warrant issuances or if the float becomes more concentrated through acquisitions or share repurchases.

SEC Filings to Watch

Several filings should be monitored closely for signs of increased dilution risk. An S-3 registration statement would signal a potential large equity offering, which could significantly increase share count. A 424B5 filing often accompanies such offerings and indicates the company is preparing to sell securities. An 8-K Item 1.01 filing might reveal new equity issuances or changes in capital structure. Additionally, a 10-Q report could show declining cash reserves or increased debt, both of which may prompt future equity raises.

How Dilution Happens

Dilution occurs when a company issues new shares to raise capital. If SPRY's Offering Ability is high, it means the company can easily conduct new equity offerings. This directly increases the total number of outstanding shares, reducing each existing shareholder’s percentage ownership. The Cash Runway score also plays a role — as cash reserves decline, the company may be forced to issue more shares to fund operations, further diluting the existing stockholder base. Convertible notes and warrants can also contribute by converting into common stock, adding to the total share count.

What Would Make This Worse

A significant worsening of SPRY’s risk profile would occur if the company begins issuing convertible notes or warrants at scale, or if it enters a major financing round with substantial dilution. Additionally, if cash reserves fall below 12 months and the company is forced to raise capital urgently, that could lead to a large issuance of new shares. An increase in Offering Ability combined with a drop in Cash Runway would compound risks, potentially signaling a near-term need for equity funding.

Key Insight

While dilution is inherently risky, the current risk factors are manageable as long as SPRY maintains its cash runway and avoids large-scale equity offerings.

How to Monitor SPRY for Dilution Risk

What This Risk Level Means

For an operating company like ARS Pharmaceuticals, Inc., a medium dilution risk profile reflects a moderate exposure to potential equity dilution. Small-cap companies often rely on capital raises to fund operations and growth, which inherently increases dilution risk. With a diluted equity structure, investors must remain vigilant about changes in ownership percentage and the potential for future issuance of new shares. This level of risk is particularly relevant for smaller companies that may not have robust financial buffers or established funding channels.

What Typically Happens Next

Companies with this profile often proceed through financing activities such as shelf registrations, ATM programs, or warrant exercises. These mechanisms allow the company to raise capital without immediate dilution pressure but can become problematic if overused or executed rapidly. The timing of these events is critical — typically occurring during periods of financial stress or strategic expansion phases. Monitoring for filings related to these programs is essential to anticipate changes in share count and ownership.

Monitoring Playbook

To track SPRY effectively, use DilutionWatch to set up alerts for key events like new offerings or warrant exercises. Check scores weekly and monitor the company’s SEC filings closely. Set thresholds for any score exceeding 50/100, triggering a deeper dive into recent transactions. When thresholds are hit, review the company's latest 8-Ks, S-1s, and other relevant documents to assess the nature of upcoming dilution.

Early Warning Signals

Three key warning signs include: a sudden spike in Offering Ability or Float Risk scores, an announcement of a shelf registration or ATM program filing, and a significant increase in warrant exposure. These signals indicate that the company is preparing to issue new equity, potentially leading to further dilution. Additionally, any change in convertible note risk levels should be closely observed as these instruments can convert into common stock under certain conditions.

What a Positive Resolution Looks Like

A positive shift would occur if the company raises capital through debt or equity that reduces overall exposure, such as completing a large capital raise or allowing warrants to expire without exercise. Another resolution path involves reducing convertible note obligations, which can lower dilution risk. Tracking Shelf & ATM Monitor for any reduction in pending offerings also helps identify when the company is taking steps to stabilize its capital structure.

Watch For

Any sudden increase in Offering Ability or Float Risk scores, especially if accompanied by new SEC filings related to equity issuance.

Full SEC filing analysis available with free account  →
Track SPRY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SPRY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SPRY
SPRY FDA Catalyst Timeline & Biotech Grade — BiotechSignsSPRY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.